$1.36
+0.00%
N/A+$0.00
Healthcare
Biotechnology
NASDAQ
활발히 거래 중
Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is ...
Inovio Pharmaceuticals, Inc. is a biotechnology firm dedicated to the research, development, and market introduction of DNA-based treatments. Its core mission is ...
C-레벨 임원은 회사의 재무 전략과 혁신을 이끄는 응집된 리더십 팀입니다.
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
| Jacqueline E. Shea | 최고경영자, 사장 및 이사 | USD 889,099 | — | 1966 | Active |
| Laurent Humeau | 최고과학책임자 및 과학자문위원회 위원장 | USD 794,082 | — | 1967 | Active |
| Michael Sumner | 최고의료책임자 및 개발 총괄 | USD 653,475 | — | 1965 | Active |
| Peter D. Kies | 최고재무책임자 | USD 598,278 | 1963 | Active | |
| Robert L. Crotty | 법무총괄, 사무총장 및 최고준법책임자 | — | 1974 | Active | |
| E. J. Brandreth | 품질보증 선임부사장 | — | — | Active | |
| Robert J. Juba Jr. | 생물학적 제조 및 임상 공급 관리 선임부사장 | — | — | Active | |
| Jeffrey Skolnik | 임상 개발 선임부사장 | — | — | — | Active |
| Shawn D. Bridy | 사업 개발 선임부사장 | — | — | Active | |
| Jennie Willson | 커뮤니케이션 이사 | — | — | Active |
| Filing Date | Year | Name | Position | Level | Salary | Bonus | Stock Award | Option Award | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-07 | 2025 | Jacqueline E. Shea, Ph.D. | President President and Chief Chief Executive Officer | Founder / CEO | $728.00K | $0 | $346.10K | $351.95K | $144.14K | $16.95K | $1.59M |
| 2026-04-07 | 2025 | Michael Sumner, M.D. | Chief Chief Medical Officer and Head of Development | C-Level | $548.71K | $0 | $127.61K | $129.55K | $87.39K | $17.38K | $910.64K |
| 2026-04-07 | 2025 | Peter D. Kies | Chief Chief Financial Officer | C-Level | $514.60K | $0 | $117.48K | $117.93K | $68.24K | $15.44K | $833.68K |
| 2026-04-07 | 2024 | Jacqueline E. Shea, Ph.D. | President President and Chief Chief Executive Officer | Founder / CEO | $728.00K | $0 | $490.82K | $475.98K | $340.70K | $15.17K | $2.05M |
| 2026-04-07 | 2024 | Michael Sumner, M.D. | Chief Chief Medical Officer and Head of Development | C-Level | $532.00K | $47.13K | $139.60K | $136.32K | $167.11K | $15.25K | $1.04M |
| 2026-04-07 | 2024 | Peter D. Kies | Chief Chief Financial Officer | C-Level | $506.81K | $0 | $131.96K | $127.98K | $158.12K | $15.20K | $940.07K |
Sum of disclosed compensation by year (USD million)
Top founder/C-level executives over time (USD million)